兽医影像市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球兽医影像市场价值为 21 亿美元，预计到 2034 年将以 6.6% 的复合年增长率成长，达到 40 亿美元。动物疾病发病率的不断上升以及动物保健领域对准确、非侵入性诊断的日益增长的偏好，推动了该市场的显着增长。随着兽医护理变得越来越先进，影像系统正在成为早期疾病检测和治疗计划的重要工具。数位放射成像、超音波、电脑断层扫描 (CT) 和磁振造影 (MRI) 等成像方式的创新提高了诊断的精确度和速度，使兽医能够更准确地识别问题并及时采取干预措施。宠物主人，尤其是较发达地区的宠物主人，越来越倾向于为他们的动物提供与人类医学相同水平的护理，这推动了对兽医成像技术的需求。

对动物保健基础设施的投资不断增加以及对诊断技术的认识不断提高也促进了市场的上升趋势。影像系统在兽医研究和培训机构中也发挥关键作用，进一步支持它们融入主流兽医实践。影像工具在早期识别肿瘤和肌肉骨骼疾病等疾病方面的应用日益广泛，巩固了其在现代兽医护理中的作用。从本质上讲，兽医成像对于提供高品质的护理来说正变得越来越不可或缺，其日益增长的重要性反映在世界范围内采用率的不断提高。

根据产品细分，市场包括兽医成像仪器、软体和试剂。其中，兽医成像仪器占据主导地位，2024 年价值为 12 亿美元。该领域包括各种技术，例如放射系统、超音波系统、CT 扫描仪、MRI 机器、视讯内视镜装置、核成像设备和其他成像平台。兽医诊所越来越多地采用这些系统来诊断各种健康状况。人们对早期疾病检测的认识不断提高，加上允许更高解析度成像和更快处理时间的进步，正在加速将这些工具整合到日常兽医操作中。宠物收养数量的增长、兽医诊所数量的激增以及对动物健康的日益重视，进一步提升了对影像仪器的需求。

根据动物类型，市场分为小型伴侣动物、大型动物和其他动物。 2024 年，小型伴侣动物市场以 49% 的市占率领先全球市场。这个类别包括狗和猫等动物，它们的数量正在显着增加，尤其是在城市家庭中。随着人们对宠物健康的日益关注和获得兽医服务的增加，宠物主人在医疗诊断和治疗上的花费也越来越多。此外，宠物保险覆盖范围的扩大使得兽医支出增加，从而支持该领域在预测期内持续成长。

在应用方面，市场分为骨科和创伤科、肿瘤科、心臟科、神经科等。骨科和创伤学领域是领先的应用领域，预计到 2034 年将产生 14 亿美元的产值。对损伤和肌肉骨骼疾病的精确诊断成像的需求日益增长，推动了该领域的需求。 X 光、MRI 和 CT 扫描等技术被广泛用于评估骨骼、关节和韧带的状况。提供清晰、详细的视觉效果有助于准确的诊断并有助于规划有效的治疗，这是该领域强大的市场份额的关键因素。此外，向微创治疗的转变正在鼓励采用先进的影像解决方案。

根据最终用途，市场包括兽医医院和诊所、诊断影像中心和其他场所。兽医院和诊所占据了 2024 年最大的市场份额，预计到 2034 年将以 6.4% 的复合年增长率增长。这些机构拥有更多资源投资于成像系统，并且通常是第一个采用新技术的机构。政府支持发展现代化医疗基础设施的措施也增强了获得先进兽医服务的机会。医院和诊所越来越多地将高端诊断工具整合到他们的服务中，以提供更好的结果并提高护理质量，从而推动该领域的市场成长。

光是美国兽医成像市场在 2024 年就达到 8.18 亿美元，占全球市场的很大份额。这一增长是由完善的医疗保健框架、对先进兽医诊断的高需求以及主要市场参与者的强大影响力所推动的。宠物拥有量的增加以及兽医实践中高科技诊断解决方案的采用正在加强该国在全球地位。人们对宠物健康的认识不断提高，对早期疾病诊断的关注度不断提高，并继续支持美国影像技术的推广

这个竞争激烈的市场中的知名公司包括爱克发吉华集团、BCF、佳能医疗系统公司、锐珂医疗、Epica International、百胜、EI Medical Imaging、富士胶片控股公司、通用电气医疗集团、赫斯卡公司、爱德士实验室、IMV Imaging、柯尼卡美能达、深迈迈子库、深迈子医疗技术有限公司和西迈子。这些公司正在跨产品线进行创新，整合人工智慧技术，并专注于开发便携式、高效的成像设备。战略合作伙伴关係和新地域扩张也帮助他们加强了全球市场影响力。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 宠物拥有量和支出增加
    • 成像技术的进步
    • 动物疾病发生率上升
    • 已开发经济体兽医数量不断增加
  • 产业陷阱与挑战
    • 兽医影像仪器成本高昂
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 兽医成像仪器
  • 放射线照相（X射线）系统
  • 超音波系统
  • 电脑断层扫描系统
  • 磁振造影系统
  • 视讯内视镜成像系统
  • 核子造影扫描仪
  • 其他成像系统
• 兽医软体
• 兽医成像试剂
  • 超音波造影试剂
  • MRI造影剂
  • X射线/CT造影试剂
  • 核子造影试剂

第六章：市场估计与预测：依动物类型，2021 - 2034 年

• 主要趋势
• 小型伴侣动物
  • 狗
  • 猫
  • 其他小型伴侣动物
• 大型动物
  • 马
  • 牛
  • 其他大型动物
• 其他动物

第七章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 骨科和创伤学
• 肿瘤学
• 心臟病学
• 神经病学
• 其他应用

第八章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 兽医医院和诊所
• 诊断影像中心
• 其他最终用途

第九章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• Agfa-Gevaert Group
• BCF
• Canon Medical Systems Corporation
• Carestream Health
• Epica International
• Esaote
• EI Medical Imaging
• Fujifilm Holdings Corporation
• GE Healthcare
• Heska Corporation
• IDEXX Laboratories
• IMV imaging
• Konica Minolta
• Shenzhen Mindray Animal Medical Technology
• Siemens Healthineers

The Global Veterinary Imaging Market was valued at USD 2.1 billion in 2024 and is estimated to grow at a CAGR of 6.6% to reach USD 4 billion by 2034. The increasing incidence of animal diseases and the rising preference for accurate, non-invasive diagnostics in animal healthcare are driving significant growth in this market. With veterinary care becoming more advanced, imaging systems are emerging as essential tools for early disease detection and treatment planning. Innovations in imaging modalities such as digital radiography, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) have enhanced the precision and speed of diagnostics, allowing veterinarians to identify issues with greater accuracy and initiate timely interventions. Pet owners, especially in more developed regions, are increasingly inclined toward offering their animals the same level of care expected in human medicine, boosting the demand for veterinary imaging technologies.

Growing investments in animal healthcare infrastructure and heightened awareness around diagnostic technologies are also contributing to the market's upward trajectory. Imaging systems are playing a critical role in veterinary research and training institutions as well, further supporting their integration into mainstream veterinary practices. The expanding application of imaging tools for the early identification of conditions like tumors and musculoskeletal disorders is solidifying their role in modern veterinary care. In essence, veterinary imaging is becoming indispensable for offering high-quality care, and its growing significance is reflected in the increasing adoption rates worldwide.

The market, based on product segmentation, includes veterinary imaging instruments, software, and reagents. Among these, veterinary imaging instruments held the dominant share, valued at USD 1.2 billion in 2024. This segment includes a variety of technologies, such as radiography systems, ultrasound systems, CT scanners, MRI machines, video endoscopy units, nuclear imaging devices, and other imaging platforms. These systems are being increasingly adopted across veterinary clinics to diagnose a wide range of health conditions. Rising awareness around early disease detection, combined with advances that allow higher-resolution imaging and faster processing times, is accelerating the integration of these tools into daily veterinary operations. The growth in pet adoption, the surge in veterinary clinic openings, and the heightened emphasis on animal health are further elevating the demand for imaging instruments.

When examined by animal type, the market is categorized into small companion animals, large animals, and others. The small companion animals segment led the global market in 2024 with a 49% share. This category includes animals such as dogs and cats, which are experiencing a notable rise in population, particularly in urban households. With growing attention to pet health and increased access to veterinary services, pet owners are spending more on medical diagnostics and treatments. Additionally, the expansion of pet insurance coverage is enabling higher veterinary expenditure, supporting sustained growth in this segment through the forecast period.

In terms of application, the market is segmented into orthopedics and traumatology, oncology, cardiology, neurology, and others. The orthopedics and traumatology segment stood out as the leading application area, and it is expected to generate USD 1.4 billion by 2034. The increasing need for precise diagnostic imaging for injuries and musculoskeletal disorders is fueling demand in this segment. Technologies such as X-rays, MRI, and CT scans are extensively used to evaluate conditions involving bones, joints, and ligaments. The ability to deliver clear, detailed visuals supports accurate diagnoses and aids in planning effective treatments, which is a key factor behind the strong market share of this segment. Additionally, the shift toward minimally invasive treatments is encouraging the adoption of advanced imaging solutions.

Based on end use, the market includes veterinary hospitals and clinics, diagnostic imaging centers, and other settings. Veterinary hospitals and clinics accounted for the largest market share in 2024 and are anticipated to grow at a CAGR of 6.4% through 2034. These facilities have more resources to invest in imaging systems and are typically the first to adopt new technologies. Government initiatives supporting the development of modern healthcare infrastructure are also enhancing access to advanced veterinary services. Hospitals and clinics are increasingly integrating high-end diagnostic tools into their services to deliver better outcomes and elevate the quality of care, fueling market growth in this segment.

The U.S. veterinary imaging market alone reached USD 818 million in 2024, holding a major share of the global market. This growth is driven by a well-developed healthcare framework, high demand for advanced veterinary diagnostics, and a strong presence of leading market players. The rise in pet ownership and the adoption of high-tech diagnostic solutions across veterinary practices are strengthening the country's position in the global landscape. Greater awareness of pet health and a growing focus on early disease diagnosis continue to support the expansion of imaging technologies in the U.S.

Prominent companies in this competitive market include Agfa-Gevaert Group, BCF, Canon Medical Systems Corporation, Carestream Health, Epica International, Esaote, E.I. Medical Imaging, Fujifilm Holdings Corporation, GE Healthcare, Heska Corporation, IDEXX Laboratories, IMV imaging, Konica Minolta, Shenzhen Mindray Animal Medical Technology, and Siemens Healthineers. These companies are innovating across product lines, integrating AI technologies, and focusing on developing portable and efficient imaging devices. Strategic partnerships and expansions into new geographies are also helping them strengthen their global market presence.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing pet ownership and expenditure
    • 3.2.1.2 Advancements in imaging technologies
    • 3.2.1.3 Rising prevalence of animal diseases
    • 3.2.1.4 Rising number of veterinary practitioners in developed economies
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with veterinary imaging instruments
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter’s analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Veterinary imaging instruments
  • 5.2.1 Radiography (X-ray) systems
  • 5.2.2 Ultrasound systems
  • 5.2.3 Computed tomography systems
  • 5.2.4 Magnetic resonance imaging systems
  • 5.2.5 Video endoscopy imaging systems
  • 5.2.6 Nuclear imaging scanners
  • 5.2.7 Other imaging systems
• 5.3 Veterinary software
• 5.4 Veterinary imaging reagents
  • 5.4.1 Ultrasound contrast reagents
  • 5.4.2 MRI contrast reagents
  • 5.4.3 X-ray/CT contrast reagents
  • 5.4.4 Nuclear imaging reagents

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Small companion animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Other small companion animals
• 6.3 Large animals
  • 6.3.1 Horse
  • 6.3.2 Cattle
  • 6.3.3 Other large animals
• 6.4 Other animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Orthopedics and traumatology
• 7.3 Oncology
• 7.4 Cardiology
• 7.5 Neurology
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals and clinics
• 8.3 Diagnostic imaging centers
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Agfa-Gevaert Group
• 10.2 BCF
• 10.3 Canon Medical Systems Corporation
• 10.4 Carestream Health
• 10.5 Epica International
• 10.6 Esaote
• 10.7 E.I. Medical Imaging
• 10.8 Fujifilm Holdings Corporation
• 10.9 GE Healthcare
• 10.10 Heska Corporation
• 10.11 IDEXX Laboratories
• 10.12 IMV imaging
• 10.13 Konica Minolta
• 10.14 Shenzhen Mindray Animal Medical Technology
• 10.15 Siemens Healthineers